Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Cholestatic jaundice in infancy: struggling with many old and new phenotypes.

Mandato C, Zollo G, Vajro P.

Ital J Pediatr. 2019 Jul 17;45(1):83. doi: 10.1186/s13052-019-0679-x.

2.

Humanization interventions in general pediatric wards: a systematic review.

Tripodi M, Siano MA, Mandato C, De Anseris AGE, Quitadamo P, Guercio Nuzio S, Siani P, Vajro P.

Eur J Pediatr. 2019 May;178(5):607-622. doi: 10.1007/s00431-019-03370-3. Epub 2019 Apr 4.

PMID:
30949888
3.

Hepatitis B virus and the paediatric liver: waiting for news on the horizon.

Mandato C, Guercio Nuzio S, Vajro P.

Acta Paediatr. 2019 Jun;108(6):989-991. doi: 10.1111/apa.14764. Epub 2019 Mar 13. No abstract available.

PMID:
30868651
4.

Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome.

Troisi J, Belmonte F, Bisogno A, Pierri L, Colucci A, Scala G, Cavallo P, Mandato C, Di Nuzzi A, Di Michele L, Delli Bovi AP, Guercio Nuzio S, Vajro P.

Nutrients. 2019 Jan 26;11(2). pii: E274. doi: 10.3390/nu11020274.

5.

Correction: Hammad, A.; Kaido, T.; Aliyev V.; Mandato C.; Uemoto S. Nutritional Therapy in Liver Transplantation. Nutrients 2017; 9. E1126.

Hammad A, Kaido T, Aliyev V, Mandato C, Uemoto S.

Nutrients. 2018 Dec 18;10(12). pii: E2006. doi: 10.3390/nu10122006.

6.

Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease.

Alfani R, Vassallo E, De Anseris AG, Nazzaro L, D'Acunzo I, Porfito C, Mandato C, Vajro P.

Children (Basel). 2018 Dec 13;5(12). pii: E169. doi: 10.3390/children5120169. Review.

7.

Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new.

Mandato C, D'Acunzo I, Vajro P.

Dig Liver Dis. 2018 Nov;50(11):1163-1165. doi: 10.1016/j.dld.2018.08.026. Epub 2018 Sep 1. No abstract available.

PMID:
30262159
8.

Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation.

Vajro P, Zielinska K, Ng BG, Maccarana M, Bengtson P, Poeta M, Mandato C, D'Acunto E, Freeze HH, Eklund EA.

Orphanet J Rare Dis. 2018 Jan 10;13(1):4. doi: 10.1186/s13023-017-0757-3.

9.

Nutrition and Liver Disease.

Mandato C, Di Nuzzi A, Vajro P.

Nutrients. 2017 Dec 23;10(1). pii: E9. doi: 10.3390/nu10010009.

10.

Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis?

Clemente MG, Antonucci R, Mandato C, Cicotto L, Meloni A, Gridelli B, De Virgiliis S, Manns MP, Vajro P.

Biomed Res Int. 2017;2017:3563278. doi: 10.1155/2017/3563278. Epub 2017 Nov 27.

11.

Nutritional Therapy in Liver Transplantation.

Hammad A, Kaido T, Aliyev V, Mandato C, Uemoto S.

Nutrients. 2017 Oct 16;9(10). pii: E1126. doi: 10.3390/nu9101126. Review. Erratum in: Nutrients. 2018 Dec 18;10(12):.

12.

Humanization of pediatric care in the world: focus and review of existing models and measurement tools.

Tripodi M, Siano MA, Mandato C, De Anseris AGE, Quitadamo P, Guercio Nuzio S, Viggiano C, Fasolino F, Bellopede A, Annunziata M, Massa G, Pepe FM, De Chiara M, Siani P, Vajro P.

Ital J Pediatr. 2017 Aug 30;43(1):76. doi: 10.1186/s13052-017-0394-4. Review.

13.

Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature.

Mandato C, Rossi A, Caldore M, Lamba M, Rocco M, Auricchio R, Vajro P, Siani P.

Clin Res Hepatol Gastroenterol. 2018 Feb;42(1):e7-e13. doi: 10.1016/j.clinre.2017.05.002. Epub 2017 Jun 9.

PMID:
28606713
14.

Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.

Clemente MG, Mandato C, Poeta M, Vajro P.

World J Gastroenterol. 2016 Sep 28;22(36):8078-93. doi: 10.3748/wjg.v22.i36.8078. Review.

15.

Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.

Orso G, Mandato C, Veropalumbo C, Cecchi N, Garzi A, Vajro P.

Dig Liver Dis. 2016 Mar;48(3):215-22. doi: 10.1016/j.dld.2015.11.003. Epub 2015 Nov 14. Review.

PMID:
26698410
16.

Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.

Paolella G, Mandato C, Pierri L, Poeta M, Di Stasi M, Vajro P.

World J Gastroenterol. 2014 Nov 14;20(42):15518-31. doi: 10.3748/wjg.v20.i42.15518. Review.

17.

Management of adults with paediatric-onset chronic liver disease: strategic issues for transition care.

Vajro P, Ferrante L, Lenta S, Mandato C, Persico M.

Dig Liver Dis. 2014 Apr;46(4):295-301. doi: 10.1016/j.dld.2013.10.018. Epub 2013 Dec 8. Review.

PMID:
24321359
18.

More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease.

Vajro P, Mandato C, D'Aniello R.

Hepat Mon. 2013 Aug 27;13(8):e13780. doi: 10.5812/hepatmon.13780. eCollection 2013. No abstract available.

19.

Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease.

Vajro P, Mandato C, Veropalumbo C, De Micco I.

Ann Hepatol. 2013 Jan-Feb;12(1):161-3. No abstract available.

20.

Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease.

Vajro P, Mandato C, Licenziati MR, Franzese A, Vitale DF, Lenta S, Caropreso M, Vallone G, Meli R.

J Pediatr Gastroenterol Nutr. 2011 Jun;52(6):740-3. doi: 10.1097/MPG.0b013e31821f9b85.

PMID:
21505361

Supplemental Content

Loading ...
Support Center